789 related articles for article (PubMed ID: 36544369)
21. Citicoline in vascular cognitive impairment and vascular dementia after stroke.
Alvarez-Sabín J; Román GC
Stroke; 2011 Jan; 42(1 Suppl):S40-3. PubMed ID: 21164117
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study.
Cotroneo AM; Castagna A; Putignano S; Lacava R; Fantò F; Monteleone F; Rocca F; Malara A; Gareri P
Clin Interv Aging; 2013; 8():131-7. PubMed ID: 23403474
[TBL] [Abstract][Full Text] [Related]
23. [Influence of neuroprotectors with choline-positive action on the level of brain-injury markers during acute ischemic stroke].
Vaizova OE; Zautner NA; Alifirova VM; Vengerovskiĭ AI
Eksp Klin Farmakol; 2012; 75(3):7-9. PubMed ID: 22679745
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective properties of citicoline: facts, doubts and unresolved issues.
Grieb P
CNS Drugs; 2014 Mar; 28(3):185-93. PubMed ID: 24504829
[TBL] [Abstract][Full Text] [Related]
25. The effects of citicoline on acute ischemic stroke: a review.
Overgaard K
J Stroke Cerebrovasc Dis; 2014 Aug; 23(7):1764-9. PubMed ID: 24739589
[TBL] [Abstract][Full Text] [Related]
26. CDP-choline, but not cytidine, protects hippocampal CA1 neurones in the gerbil following transient forebrain ischaemia.
Grieb P; Gadamski R; Wojda R; Janisz M
Folia Neuropathol; 2001; 39(3):141-5. PubMed ID: 11770124
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotection and recovery: recent data at the bench on citicoline.
Hurtado O; Lizasoain I; Moro MÁ
Stroke; 2011 Jan; 42(1 Suppl):S33-5. PubMed ID: 21164125
[TBL] [Abstract][Full Text] [Related]
28. Effect of citicoline on functional and cognitive status among patients with traumatic brain injury: Citicoline Brain Injury Treatment Trial (COBRIT).
Zafonte RD; Bagiella E; Ansel BM; Novack TA; Friedewald WT; Hesdorffer DC; Timmons SD; Jallo J; Eisenberg H; Hart T; Ricker JH; Diaz-Arrastia R; Merchant RE; Temkin NR; Melton S; Dikmen SS
JAMA; 2012 Nov; 308(19):1993-2000. PubMed ID: 23168823
[TBL] [Abstract][Full Text] [Related]
29. How effective is citicoline for acute ischaemic stroke?
Hankey GJ
Lancet; 2012 Jul; 380(9839):318-20. PubMed ID: 22691568
[No Abstract] [Full Text] [Related]
30. The role of citicoline in cognitive impairment: pharmacological characteristics, possible advantages, and doubts for an old drug with new perspectives.
Gareri P; Castagna A; Cotroneo AM; Putignano S; De Sarro G; Bruni AC
Clin Interv Aging; 2015; 10():1421-9. PubMed ID: 26366063
[TBL] [Abstract][Full Text] [Related]
31. Citicoline (CDP-choline) increases Sirtuin1 expression concomitant to neuroprotection in experimental stroke.
Hurtado O; Hernández-Jiménez M; Zarruk JG; Cuartero MI; Ballesteros I; Camarero G; Moraga A; Pradillo JM; Moro MA; Lizasoain I
J Neurochem; 2013 Sep; 126(6):819-26. PubMed ID: 23600725
[TBL] [Abstract][Full Text] [Related]
32. Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes.
Cohen RA; Browndyke JN; Moser DJ; Paul RH; Gordon N; Sweet L
Cerebrovasc Dis; 2003; 16(3):199-204. PubMed ID: 12865605
[TBL] [Abstract][Full Text] [Related]
33. [The assessment of the efficacy of citicoline in the early and recovery stages of stroke].
Shavlovskaya OA
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(6):93-97. PubMed ID: 28635796
[TBL] [Abstract][Full Text] [Related]
34. Application of Citicoline in Neurological Disorders: A Systematic Review.
Jasielski P; Piędel F; Piwek M; Rocka A; Petit V; Rejdak K
Nutrients; 2020 Oct; 12(10):. PubMed ID: 33053828
[TBL] [Abstract][Full Text] [Related]
35. Citicoline, use in cognitive decline: vascular and degenerative.
García-Cobos R; Frank-García A; Gutiérrez-Fernández M; Díez-Tejedor E
J Neurol Sci; 2010 Dec; 299(1-2):188-92. PubMed ID: 20875651
[TBL] [Abstract][Full Text] [Related]
36. [The current state of citicholine in cerebral ischemia].
Abad-Santos F; Gallego-Sandín S; Novalbos J; Gálvez-Múgica MA
Rev Neurol; 2000 Apr 1-15; 30(7):663-70. PubMed ID: 10859748
[TBL] [Abstract][Full Text] [Related]
37. Medical treatment of amblyopia: present state and perspectives.
Campos EC; Fresina M
Strabismus; 2006 Jun; 14(2):71-3. PubMed ID: 16760111
[TBL] [Abstract][Full Text] [Related]
38. Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis.
Bonvicini M; Travaglini S; Lelli D; Antonelli Incalzi R; Pedone C
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678257
[TBL] [Abstract][Full Text] [Related]
39. Recovery Trajectories and Long-Term Outcomes in Traumatic Brain Injury: A Secondary Analysis of the Phase 3 Citicoline Brain Injury Treatment Clinical Trial.
Puffer RC; Yue JK; Mesley M; Billigen JB; Sharpless J; Fetzick AL; Puccio AM; Diaz-Arrastia R; Okonkwo DO
World Neurosurg; 2019 May; 125():e909-e915. PubMed ID: 30763755
[TBL] [Abstract][Full Text] [Related]
40. [Multicenter observational program for evaluation of the effectiveness of the recognan (citicoline) in the correction of cognitive impairment in patients with chronic cerebrovascular pathology].
Mashin VV; Belova LA; Bakhtogarimov IR; Bergelson TM; Sharafutdinova RR
Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):39-43. PubMed ID: 28884715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]